Histamine H3 receptors and their role in basal ganglia physiology and pathophysiology
Abstract
Through interaction with G protein-coupled receptors, histamine regulates pre- and post-synaptically a number of brain functions such as wakefulness, locomotor activity, autonomic and vestibular functions, feeding, drinking, analgesia and memory. Four such receptors have been cloned to date, and three of them (H1, H2, and H3) are widely distributed in the central nervous system, which contains the great majority of histamine H3 receptors (H3Rs). These receptors are expressed at high densities in the basal ganglia, a group of subcortical neuronal nuclei intimately involved in the regulation of posture and movement. In this review the main characteristics of H3Rs (structure, isoforms, constitutive activity and signaling) are briefly described, to then summarize our own work regarding the H3R-mediated regulation of synaptic transmission in the basal ganglia. Finally, the possible participation of H3Rs in the pathophysiology of Parkinson's disease is discussed. Based on the information herein reviewed it is concluded that H3Rs play a relevant role in basal ganglia function both in normal and pathological conditions, and that H3R agonists and antagonists may have potential use in the treatment of both Parkinson's disease and the complications of the current pharmacological therapies of the disorder.
References
- [1] Haas, H., Panula, P. (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nature Rev. Neurosci. 4: 121–130.
- [2] Leurs, R., Bakker, R.A., Timmeman, H., de Esch, J.P. (2005) The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nature Rev. Drug Discov. 4: 107–121.
- [3] Poli, E., Coruzzi, G., Bertaccini, G. (1991) Histamine H3 receptors regulate acetylcholine release from the guinea pig ileum myenteric plexus. Life Sci. 48: 63–68.
- [4] Silver, R.B., Poonwasi, K.S., Seyedi, N., Wilson, S.J., Lovenberg, T.W., Levi, R. (2002) Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings. Proc. Natl. Acad. Sci. U.S.A. 99: 501–506.
- [5] Pillot, C., Héron, A., Cochois, V., Tardivel-Lacombe, J., Ligneau, X., Schwartz, J.-C., Arrang, J.-M. (2002) A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain. Neuroscience 114: 173–193.
- [6] Arrang, J.-M., Garbarg, M., Schwartz, J.-C. (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832–837.
- [7] Arrang, J.-M., Garbarg, M., Schwartz, J.-C. (1987) Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors. Neuroscience 23: 149–157.
- [8] Schlicker, E., Betz, R., Göthert, M. (1988) Histamine H3-receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 337: 588–590.
- [9] Schlicker, E., Fink, K., Hinterhaner, M., Göthert, M. (1989) Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 633–638.
- [10] Ichinose, M., Barnes, P.J. (1989) Histamine H3-receptors modulate nonadrenergic noncholinergic neural bronchoconstriction in guinea-pig in vivo. Eur. J. Pharmacol. 174: 49–55.
- [11] Hew, R.W., Hodgkinson, C.R., Hill, S.J. (1990) Characterization of histamine H3-receptors in guinea-pig ileum with H3-selective ligands. Br. J. Pharmacol. 101: 621–624.
- [12] Schlicker, E., Fink, K., Detzner, M., Göthert, M. (1993) Histamine inhibits dopamine release in the mouse striatum via presynaptic H3-receptors. J. Neural Transm. 93: 1–10.
- [13] Doreulee, N., Yanovsky, Y., Flagmeyer, I., Stevens, D.R., Haas, H.L., Brown, R.E. (2001) Histamine H3 receptors depress synaptic transmission in the corticostriatal pathway. Neuropharmacology 40: 106–113.
- [14] Molina-Hernández, A., Nuñez, A., Sierra, J.J., Arias-Montaño, J.A. (2001) Histamine H3 receptor activation inhibits glutamate release from rat striatal synaptosomes. Neuropharmacology 41: 928–934.
- [15] García, M., Florán, B., Arias-Montaño, J.A., Aceves, J., Young, J.M. (1997) Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarisation-stimulated slices of rat substantia nigra pars reticulata. Neuroscience 80: 241–249.
- [16] Arias-Montaño, J.A., Florán, B., García, M., Aceves, J., Young, J.M. (2001) Histamine H3 receptor-mediated inhibition of depolarisation-induced, dopamine D1 receptor-dependent release of [3H]-γ-aminobutyric acid in rat striatum. Br. J. Pharmacol. 133: 165–171.
- [17] Lovenberg, T.W., Roland, B.L., Wilson, S.J., Jiang, X., Pyati, J., Huvar, A., Jackson, M.R., Erlander, M.G. (1999) Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol. 55: 1101–1107.
- [18] Bongers, G., Bakker, R.A., Leurs, R. (2007) Molecular aspects of the histamine H3 receptor. Biochem. Pharmacol. 73: 1195–1204.
- [19] Bongers, G., Krueger, K.M., Miller, T.R., Baranowski, J.L., Estvander, B.R., Witte, D.G., Strakhova, M.I., van Meer, P., Bakker, R.A., Cowart, M.D., Hancock, A.A., Esbenshade, T.A., Leurs, R. (2007) A 80-amino acid deletion in the third intracellular loop of a naturally occurring human histamine H3 isoform confers pharmacological differences and constitutive activity. J. Pharmacol. Exp. Ther. 323: 888–898.
- [20] Bakker, R.A. (2004) Histamine H3-receptor isoforms. Inflamm. Res. 53: 509–516.
- [21] Strakhova, M.I., Fox, G.B., Carr, T.L., Witte, D.G., Yao, B.B., Manelli, A.M., Vorthems, T.A., Miller, T.R., Brioni, J.D., Esbenshade, T.A. (2007) Cloning and characterization of CNS expression, ligand binding, and functional properties of multiple monkey H3 receptor isoforms. Society for Neuroscience Abstracts, 878.1/G21.
- [22] Bakker, R.A., Flores-Lozada, A., van Marle, A., Shenton, F.C., Drutel, G., Karlstedt, K., Hoffmann, M., Lintunen, M., Yamamoto, Y., van Rijn, R.M., Chazot, P.L., Panula, P., Leurs, R. (2006) Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms. Mol. Pharmacol. 69: 1194–1206.
- [23] Arrang, J.-M., Morisset, S., Gbahou, S. (2007) Constitutive activity of the histamine H3 receptor. Trends Pharmacol. Sci. 28: 350–357.
- [24] Morisset, S., Rouleau, A., Ligneau, X., Gbahou, F., Tardivel-Lacombe, J., Stark, H., Schunack, W., Ganellin, C.R., Arrang, J.-M. (2000) High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408: 860–864.
- [25] Rouleau, A., Ligneau, X., Tardivel-Lacombe, J., Morisset, S., Gbahou, Schwartz, J.-C., Arrang, J.-M. (2002) Histamine H3-receptor-mediated [35S]GTPg[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors. Br. J. Pharmacol. 135: 383–392.
- [26] Takeshita, Y., Watanabe, T., Sakata, T., Munakata, M., Ishibashi, H., Akaike, N. (1998) Histamine modulates high-voltage-activated calcium channels in neurons dissociated from the rat tuberomammillary nucleus. Neuroscience 87: 797–805.
- [27] Silver, R.B., Mackins, C.J., Smith, N.C., Koritchneva, I.L., Lefkowitz, K., Lovenberg, T.W., Levi, R. (2001) Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: a novel protective mechanism in myocardial ischemia. Proc. Natl. Acad. Sci. U.S.A. 98: 2855–2859.
- [28] Sahlholm, K., Nilsson, J., Marcellino, D., Fuxe, K., Arhem, P. (2007) The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes. Eur. J. Pharmacol. 567: 206–210.
- [29] Marinissen, M.J., Gutkind, J.S. (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Sci. 22: 368–376.
- [30] Bongers, G., Sallmen, T., Passani, M.B., Mariottini, C., Wendelin, D., Lozada, A., van Marle, A., Navis, M., Blandina, P., Bakker, R.A., Panula, R., Leurs, R. (2007) The Akt/GSK-3β axis as a new signaling pathway of the histamine H3 receptor. J. Neurochem. 103: 248–258.
- [31] Pollard, H., Moreau, J., Arrang, J.-M., Schwartz, J.-C. (1993) A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience 52: 169–189.
- [32] Gerfen, C.R., Wilson, C.J. (1996) The basal ganglia. In Integrated Systems of the CNS, Part III (Handbook of Chemical Neuroanatomy, Vol. 12). Eds.: Björklund, A., Hökfelt, T., Swanson, L. Elsevier, Amsterdam (The Netherlands), pp. 369–466.
- [33] Floran, B., Aceves, J., Sierra, A., Martinez-Fong, D. (1990) Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci. Lett. 116: 136–140.
- [34] Ryu, J.H., Yanai, K., Iwata, R., Ido, T., Watanabe, T. (1994) Heterogenous distribution of histamine H3, dopamine D1 and D2 receptors in rat brain. NeuroReport 5: 621–624.
- [35] Arias-Montaño, J.A., Florán, B., Florán, L., Aceves, J., Young, J.M. (2007) Dopamine D1 receptor facilitation of depolarisation-induced release of γ-aminobutyric acid (GABA) in rat striatum is mediated predominantly via P/Q-type calcium channels. Synapse 61: 310–319.
- [36] Garduño-Torres, B., Treviño, M., Gutiérrez, R., Arias-Montaño, J.A. (2007) Presynaptic histamine H3 receptors regulate glutamate, but not GABA release in rat thalamus. Neuropharmacology 52: 527–535.
- [37] Molina-Hernández, A., Nuñez, A., Arias-Montaño, J.A. (2000) Histamine H3–receptor activation inhibits dopamine synthesis in rat striatum. NeuroReport 17: 163–166.
- [38]
Gainetdinov, R.R.,
Premont, R.T.,
Bohn, L.M.,
Lefkowitz, R.J.,
Caron, M.G.
(2004)
Desensitization of G protein-coupled receptors and neuronal functions.
Annu. Rev. Neurosci.
27:
107–144.
10.1146/annurev.neuro.27.070203.144206 Google Scholar
- [39] Garduño-Torres, B., Arias-Montaño, J.A. (2006) Homologous down-regulation of histamine H3 receptors in rat striatal slices. Synapse 60: 165–171.
- [40] García-Ramírez, M., Aceves, J., Arias-Montaño, J.A. (2004) Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats. Behav. Brain Res 154: 409–415.
- [41] Sánchez-Lemus, E., Arias-Montaño, J.A. (2004) Histamine H3 receptor-mediated inhibition of dopamine D1 receptor-induced cAMP formation in rat striatum. Neurosci. Lett. 364: 179–184.
- [42] Anichtchik, O.V., Rinne, J.O., Kalimo, H., Panula, P. (2000) An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp. Neurol. 163: 20–30.
- [43] Rinne, J.O., Anichtchik, O.V., Eriksson, K.S., Kaslin, J., Tuomisto, L., Kalimo, H., Roytta, M., Panula, P. (2002) Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J. Neurochem. 81: 954–960.
- [44] Anichtchik, O.V., Peitsaro, N., Rinne, J.O., Kalimo, H., Panula, P. (2001) Distribution and modulation of histamine H3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol. Dis. 8: 707–717.
- [45] Schapira, A.H., Bezard, E., Brotchie, J., Calon, F., Collingridge, G.L., Ferger, B., Hengerer, B., Hirsch, E., Jenner, P., Le Novere, N., Obeso, J.A., Schwarzschild, M.A., Spampinato, U., Davidai, G. (2006) Novel pharmacological targets for the treatment of Parkinson's disease. Nature Rev. Drug Discov. 5: 845–854.
- [46] Santini, E., Valjent, E., Usiello, A., Carta, M., Borgkvist, A., Girault, J.-A., Hervé, D., Greengard, P., Fisone, G. (2007) Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA induced dyskinesia. J. Neurosci. 27: 6995–7005.
- [47] Gomez-Ramírez, J., Johnston, T.H., Visanji, N.P., Fox, S.H., Brotchie, J.M. (2006) Histamine H3 receptor agonists reduce L-DOPA-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Movement Disord. 21: 839–846.